Anderson Cancer Center in Houston, TX. Dr. Heymach’s professional research interests include lung cancer, mesothelioma, angiogenesis inhibitors, and biomarker development for targeted agents. He is considered among the most progressive new physicians in the treatment of malignant mesothelioma and other thoracic disease.